Inactive Instrument

Allergan, Inc. Share Price

Stocks

US0184901025

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

07/06/17	Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote	RE
02/06/17	Allergan : U.S. state, local government lawsuits over opioids face uphill battle	RE

Latest news: Allergan, Inc.

07/06/17	Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote	RE
02/06/17	Allergan : U.S. state, local government lawsuits over opioids face uphill battle	RE
16/05/17	Allergan : Several top fund managers trim Allergan stakes in first quarter	RE
16/05/17	Icahn takes new 19.8 million share stake in Conduent in first quarter	RE
12/05/17	Allergan : High-profile Snap stakeholders revealed in filings	RE
12/05/17	Allergan : High-profile Snap stakeholders revealed in filings	RE
09/05/17	Allergan : posts loss as it writes down Teva holdings	RE
09/05/17	Allergan : posts loss as it writes down Teva holdings	RE
09/05/17	Takeda Pharmaceutical : Sanofi pegs U.S. drug price rises to below healthcare inflation	RE
21/02/17	Allergan : Collapse of Kraft-Unilever tie-up extends run of failed mega-deals	RE
13/02/17	Allergan : to buy fat-fighter Zeltiq Aesthetics for $2.48 billion	RE
13/02/17	Allergan : Stada to hold takeover talks with rival suitors Cinven and Advent	RE
08/02/17	Allergan : says U.S. tax reform unlikely in 2017, sees strong year	RE

Press Releases: Allergan, Inc.

07/06/17	Allergan : to Present New Data on Chronic Migraine at the American Headache Society Meeting in Boston	PU
31/05/17	Allergan : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans	PU
23/05/17	Allergan : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%	PU
16/05/17	Allergan : Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications	PU
04/05/17	Allergan : to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego	PU

More press releases

News in other languages: Allergan, Inc.

12/05/17	Aktien New York: Dow schwächelt erneut - Einzelhandel im Fokus
12/05/17	Aktien New York Ausblick: Erneut moderate Verluste - Einzelhandel im Fokus
11/05/17	WDH/Aktien New York: Dow schwächer - Enttäuschende Unternehmenszahlen
11/05/17	Aktien New York Ausblick: Dow leicht im Minus - Quartalszahlen-Desaster bei Snap
10/05/17	Aktien New York: Leichte Einbußen im frühen Handel

Managers and Directors: Allergan, Inc.

Manager	Title	Age	Since
Scott Reents PSD	President	59	-

Director	Title	Age	Since
Scott Reents BRD	Director/Board Member	59	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+3.49%	+10.04%	+58.68%	+119.56%	1,144B
	JOHNSON & JOHNSON	+2.19%	+4.32%	+33.88%	+69.52%	625B
	ABBVIE INC.	+2.26%	+5.37%	+24.57%	+97.69%	511B
	ROCHE HOLDING AG	-0.42%	+4.29%	+37.75%	+62.83%	377B
	MERCK & CO., INC.	+3.25%	+4.45%	+71.80%	+44.44%	366B
	NOVARTIS AG	-0.23%	+2.69%	+20.47%	+49.07%	291B
	ASTRAZENECA PLC	-0.39%	+2.05%	+0.63%	+24.28%	262B
	AMGEN INC.	+3.29%	+6.32%	+44.71%	+57.43%	237B
	GILEAD SCIENCES, INC.	+2.25%	+5.81%	+27.13%	+101.17%	194B
	Average	+1.24%	+4.19%	+35.51%	+69.55%	445.32B
	Weighted average by Cap.	+0.85%	+4.68%	+40.77%	+80.85%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!